{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:23:31Z","timestamp":1778873011290,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.canrad.2016.09.012","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T12:47:09Z","timestamp":1487854029000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature"],"prefix":"10.1016","volume":"21","author":[{"given":"A.","family":"Paix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Waissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Adeduntan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.09.012_bib0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0135","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2016.09.012_bib0140","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","article-title":"Epidemiology of intracranial meningioma","volume":"57","author":"Claus","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2016.09.012_bib0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1278-3218(01)00103-2","article-title":"[Role of radiotherapy in the treatment of cerebral meningiomas]","volume":"5","author":"No\u00ebl","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.09.012_bib0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.10.053","article-title":"Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma","volume":"75","author":"Boskos","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.09.012_bib0155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-013-1074-x","article-title":"Distant metastases in meningioma: an underestimated problem","volume":"112","author":"Surov","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0160","doi-asserted-by":"crossref","first-page":"267831","DOI":"10.1155\/2015\/267831","article-title":"The role of mifepristone in meningiomas management: a systematic review of the literature","volume":"2015","author":"Cossu","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.canrad.2016.09.012_bib0165","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/01.wnl.0000271382.62776.b7","article-title":"Recurrent meningioma: salvage therapy with long-acting somatostatin analogue","volume":"69","author":"Chamberlain","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.canrad.2016.09.012_bib0170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/neuonc\/nor044","article-title":"Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma","volume":"13","author":"Johnson","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s11060-011-0541-5","article-title":"Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series","volume":"104","author":"Chamberlain","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3340\/jkns.2012.52.6.517","article-title":"Long-term follow-up result of hydroxyurea chemotherapy for recurrent meningiomas","volume":"52","author":"Kim","year":"2012","journal-title":"J Kor Neurosurg Soc"},{"key":"10.1016\/j.canrad.2016.09.012_bib0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11060-011-0687-1","article-title":"Phase II study of Gleevec\u00ae plus hydroxyurea (HU) in adults with progressive or recurrent meningioma","volume":"106","author":"Reardon","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nou148","article-title":"Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma","volume":"17","author":"Kaley","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-014-1358-9","article-title":"A phase II trial of PTK787\/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas","volume":"117","author":"Raizer","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0200","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-012-0896-2","article-title":"Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis","volume":"109","author":"Horak","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4132\/jptm.2014.10.13","article-title":"Expression of c-MET in Invasive meningioma","volume":"49","author":"Yun","year":"2015","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.canrad.2016.09.012_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08880018.2014.936058","article-title":"Metastatic rhabdoid meningioma with BRAF V600E mutation and good response to personalized therapy: case report and review of the literature","volume":"32","author":"Mordechai","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.canrad.2016.09.012_bib0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1684\/bdc.2013.1728","article-title":"Percutaneous ablation of metastases: where are we and new techniques","volume":"100","author":"Palussi\u00e8re","year":"2013","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2016.09.012_bib0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.canrad.2012.07.184","article-title":"Oligometastatic disease, a new concept: stereotactic irradiation for lung metastases. Literature review","volume":"16","author":"Hatime","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.09.012_bib0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.canrad.2012.05.016","article-title":"Oligometastatic bone disease. Can limited metastatic bone disease be cured? Is there room for local ablative treatments?","volume":"16","author":"Thariat","year":"2012","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.09.012_bib0230","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.canrad.2014.12.007","article-title":"[Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): a case report]","volume":"19","author":"Leduc","year":"2015","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:26:12Z","timestamp":1761135972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321817300112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1278321817300112"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.09.012","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}